906 followers
New article: Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy https://t.co/b8QH6CpHv0 #breastcancer #oncology https://t.co/W8cpmEckh3
New article: Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy https://t.co/b8QH6CpHv0 #breastcancer #oncology https://t.co/W8cpmEckh3
RT @FrontPharmacol: New Research: Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Mo…
New Research: Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy https://t.co/rLi8nznzIx #pharmacology